Biomarkers and intrinsic/acquired resistance mechanisms for atezolizumab plus chemoradiotherapy in MSS locally advanced rectal cancer: An exploratory analysis of a single center, phase II study

被引：0
|
作者：
Tang, W. [1 ]
Xu, J. [1 ]
Zhu, C. [2 ]
Li, X. [2 ]
Zhu, Z. [1 ]
Li, Q. [2 ]
Xu, Y. [1 ]
Zhang, X. [2 ]
机构：
[1] Fudan Univ, Colorectal Surg, Zhongshan Hosp Affiliated, Shanghai, Peoples R China
[2] Amoy Diagnost Co Ltd, Translat Med, Xiamen, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
关键词：
D O I：
10.1016/j.annonc.2024.08.154
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
146P
引用
收藏
页码：S273 / S273
页数：1
相关论文
共 50 条
  • [31] Neoadjuvant Radiotherapy with Capecitabine Plus Bevacizumab for Locally Advanced Lower Rectal Cancer: Results of a Single-institute Phase II Study
    Maeda, Kiyoshi
    Shibutani, Masatsune
    Otani, Hiroshi
    Fukuoka, Tatsunari
    Iseki, Yasuhito
    Matsutani, Shinji
    Nagahara, Hisashi
    Inoue, Toru
    Tachimori, Akiko
    Nishii, Takafumi
    Miki, Yoshitaka
    Hosono, Masako
    Ohira, Masaichi
    ANTICANCER RESEARCH, 2018, 38 (07) : 4193 - 4197
  • [32] A phase II study of neoadjuvant bevacizumab plus capecitabine and concomitant radiotherapy in patients with locally advanced rectal cancer
    Giampietro Gasparini
    Francesco Torino
    Takayuki Ueno
    Stefano Cascinu
    Teresa Troiani
    Alberto Ballestrero
    Rossana Berardi
    Junichi Shishido
    Akihiko Yoshizawa
    Yukiko Mori
    Satoshi Nagayama
    Paola Morosini
    Masakazu Toi
    Angiogenesis, 2012, 15 : 141 - 150
  • [33] A phase II study of neoadjuvant bevacizumab plus capecitabine and concomitant radiotherapy in patients with locally advanced rectal cancer
    Gasparini, Giampietro
    Torino, Francesco
    Ueno, Takayuki
    Cascinu, Stefano
    Troiani, Teresa
    Ballestrero, Alberto
    Berardi, Rossana
    Shishido, Junichi
    Yoshizawa, Akihiko
    Mori, Yukiko
    Nagayama, Satoshi
    Morosini, Paola
    Toi, Masakazu
    ANGIOGENESIS, 2012, 15 (01) : 141 - 150
  • [34] Neoadjuvant Radiochemotherapy with Capecitabine and Oxaliplatin plus bevacizumab in locally advanced Rectal Cancer - Results of a phase II study
    Dellas, K.
    Hoehler, T.
    Riesenbeck, D.
    Reese, T.
    Wuerschtnidt, F.
    Engel, E.
    Roedel, C.
    Wagner, W.
    Richter, M.
    Dunst, J.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2011, 187 : 51 - 51
  • [35] Short course chemotherapy followed by concomitant chemoradiotherapy and surgery in locally advanced rectal cancer: a randomized multicentric phase II study
    Marechal, R.
    Vos, B.
    Polus, M.
    Delaunoit, T.
    Peeters, M.
    Demetter, P.
    Hendlisz, A.
    Demols, A.
    Franchimont, D.
    Verset, G.
    Van Houtte, P.
    Van de Stadt, J.
    Van Laethem, J. L.
    ANNALS OF ONCOLOGY, 2012, 23 (06) : 1525 - 1530
  • [36] Neoadjuvant oxaliplatin and capecitabine combined with bevacizumab plus radiotherapy for locally advanced rectal cancer: results of a single-institute phase II study
    Yu, Xin
    Wang, Qiao-xuan
    Xiao, Wei-wei
    Chang, Hui
    Zeng, Zhi-fan
    Lu, Zhen-hai
    Wu, Xiao-jun
    Chen, Gong
    Pan, Zhi-zhong
    Wan, De-sen
    Ding, Pei-rong
    Gao, Yuan-hong
    CANCER COMMUNICATIONS, 2018, 38
  • [37] Neoadjuvant tislelizumab combined with CAPOX for MSS/pMMR high-risk locally advanced colon cancer: A single-arm, exploratory phase II clinical study
    Lin, M.
    Xia, Z.
    Chen, H.
    Liao, C.
    Huang, W.
    Li, H.
    Huang, J.
    Liu, M.
    Song, R.
    Xie, Y.
    Zhang, X.
    Liang, J.
    Gan, J.
    Guo, Y.
    Zhang, S.
    ANNALS OF ONCOLOGY, 2024, 35 : S21 - S21
  • [38] Phase II study of preoperative chemoradiation with S-1 plus oxaliplatin in patients with locally advanced rectal cancer
    Lee, Eun Mi
    Hong, Yong Sang
    Kim, Kyu-pyo
    Lee, Jae-Lyun
    Kim, Sun Young
    Park, Young Suk
    Choi, Doo Ho
    Kim, Jong Hoon
    Lim, Seok-Byung
    Yu, Chang Sik
    Kim, Jin Cheon
    Lee, Ju Hee
    Kim, Ah Young
    Kim, Tae Won
    CANCER SCIENCE, 2013, 104 (01) : 111 - 115
  • [39] Neoadjuvant concurrent chemoradiotherapy plus superior rectal arterial infusion chemotherapy in locally advanced rectal cancer (LARC): A pilot study from a single institute.
    Wang, Dong
    Li, Chunxue
    Shan, Jinlu
    Qing, Yi
    Li, Mengxia
    Yu, Xian
    Xiao, Hualiang
    Feng, Yan
    Li, Xuemei
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [40] A phase II study of induction chemotherapy with gemcitabine plus S-1 followed by chemoradiotherapy for locally advanced pancreatic cancer
    Nakachi, Kohei
    Furuse, Junji
    Kinoshita, Taira
    Kawashima, Mitsuhiko
    Ishii, Hiroshi
    Ikeda, Masafumi
    Mitsunaga, Shuichi
    Shimizu, Satoshi
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 66 (03) : 527 - 534
12345